T-Cell Phenotype and Function Following a First cART Regimen Containing Either a Protease Inhibitor or a Non-Nucleoside Retrotranscriptase Inhibitor in HIV-infected Late Presenters: Results From a Retrospective, Ex Vivo Study

Antiviral Therapy - United Kingdom
doi 10.3851/imp2990

Related search